Jeffrey Flier Explained

Office:21st Dean of the Harvard Medical School
Term Start:September 1, 2007
Term End:July 31, 2016
Birth Name:Jeffrey Scott Flier
Birth Date:February 27, 1948
Birth Place:New York, New York
Spouse:Eleftheria Maratos-Flier
Children:2
Website:Dean of the Faculty of Medicine
Education:City College of New York (BA)
Mount Sinai School of Medicine (MD)

Jeffrey Flier is an American physician, endocrinologist; widely cited scientist; the Higginson Professor of Medicine and Physiology at Harvard Medical School; and a Distinguished Service Professor at the same institution. He was the 21st Dean of the Faculty of Medicine at Harvard University from 2007 to 2016.[1] [2]

Early life and career

Flier was born in New York City, and grew up in the Pelham Parkway section of the Bronx. He is the son of Milton R. Flier, a World War II C-47 pilot and businessperson, and Dorothy (Kroll) Flier, who taught junior high school mathematics.[3] He graduated in 1964 from the Bronx High School of Science, and 1968 from the City College of New York. He was in the first entering class of the Mount Sinai School of Medicine in 1968, and graduated in 1972 with the Elster Prize for highest academic standing.[4] After two years of internal medicine residency at Mount Sinai Hospital, he spent four years in the Public Health Service as a clinical associate at the National Institutes of Health, completing training in endocrinology and launching a research career. He moved to Boston in 1978, becoming an assistant professor of medicine at Harvard Medical School, and chief of the Diabetes Unit at Harvard-affiliated Beth Israel Hospital. He subsequently became chief of the hospital's Endocrinology Division, vice chair for research of the Department of Medicine, and eventually the hospital's chief academic officer in 2002, overseeing research and educational affairs. At Harvard Medical School, he became the George C. Reisman Professor of Medicine, and Harvard faculty dean for Academic Affairs at what became the Beth Israel Deaconess Medical Center.[5] At BIDMC he served as a Chief Academic Officer from 2002 to 2007.[6]

Appointment as Dean of Harvard's Faculty of Medicine

Flier was appointed Dean of the Faculty of Medicine and the Caroline Shields Walker professor of medicine at Harvard in July 2007 by President Drew Faust and assumed the position on September 1, 2007.[5] During his first year as dean, he led an extensive strategic planning process, releasing a report in October 2008.[7] Harvard University and Harvard Medical School suffered financial losses when financial markets fell in 2008–2009. This slowed but did not stop investments in several areas.[8] His term as dean of Harvard Medical School ended in 2016 after nine years.[9]

Some of the corporate accomplishments corresponding to his period as a Dean were: 1. implementation of a new Clinical and Translational Science Award from NIH;[10] 2. successful launch and oversight of the $750 million “The World is Waiting” capital campaign;[11] 3. implementation of a major redesign of the preclinical medical curriculum;[12] 4. design and implementation of a new system for financial contributions to HMS from its affiliated institutions; 5. establishment of a new department of biomedical informatics;[13] 6. establishment of a new division of external education, combining Harvard Health Publishing, postgraduate medical education, and new HMS online learning and executive education programs designed to increase the global impact and educational revenues of the institution.[14] Flier's 2016 final class commencement speech at Harvard Medical School is available online.

Research contributions

While at the Diabetes Branch of NIH, under the mentorship of Jesse Roth, Philip Gorden, and C. Ronald Kahn, Flier discovered the existence of autoantibodies to the insulin receptor as a cause of severe insulin resistance.[15] This discovery elucidated a rare cause of diabetes,[16] advanced the field of membrane receptor biology and provided an important tool for research on insulin action.[17] Flier also played a major role in defining genetic causes of insulin resistance by identifying and characterizing mutations in the insulin receptor gene in a subset of patients with severe insulin resistance.[18] [19] Much of his research has addressed the pathophysiology of obesity;[20] [21] [22] In 1993, he described the dynamics of obesity in a brown-fat deficient, transgenic mouse model;[23] His most extensive work has related to the biology and pathophysiology of leptin, its physiological role in starvation,[24] and the molecular mechanisms of leptin resistance in obesity.[25] With Maratos-Flier, he studied the participation of neuropeptide MCH in feeding behavior and energy balance;[26] and the role of FGF21 in metabolic regulation.[27] With Bruce Spiegelman he discovered an altered production of adipsin in obesity in genetically obese mice.[28] In 2005, he reported the possible role of adult hypothalamic neurogenesis in the control of energy balance;[29] Regarding inflammatory phenomena in metabolic disease, Flier helped establish that Toll-like receptor 4 (TLR4) activation in adipocytes and macrophages mediates inflammation accompanying obesity, and subsequent insulin resistance in diabetes.[30] In 1980 he described a rare case of familial acanthosis nigricans-muscle cramps-acral enlargement syndrome.[31]

Opinion

Since stepping down as dean, Flier has increasingly contributed policy-oriented publications focusing on a number of issues affecting health care and biomedical research in current times, among them: health care reform[32] and its sustainability,[33] enhancing US health provider workforce,[34] the pros and cons of prevailing credit attribution practices in academia and industry,[35] the realities and options linked to the irreproducibility of research results,[36] improving the institutional handling of scientific misconduct,[37] the obsolescence of distinctions between basic and translational biomedical research,[38] and the complexities behind conflict of interest (COI) disclosure.[39]

Flier has questioned the blanket and often ineffective approach toward DEI (diversity, equity, inclusion) initiatives. He does not support mandatory diversity statements in faculty applications. [40] He does not support the removal of historic portraits in universities (which are predominantly of white men) in order to provide more inclusive environments for historically underrepresented populations, like women and minorities.[41] Flier wants fairness for all, and he has critiqued the harmful “cancel culture”. He and other leaders have asked for an objective and fair-minded adjudication for Dr. David M. Sabatini, a biologist who was fired by the Howard Hughes Medical Institute and resigned from the Whitehead Institute and MIT following an allegation of sexual misconduct.[42]

Personal life

Flier is married to Eleftheria Maratos-Flier. She is an endocrinologist and Professor of Medicine at Harvard Medical School,[43] and currently a director of clinical research at Alynylam Pharmaceuticals. The two have collaborated in several areas of research. They have two daughters. Sarah and Lydia, both of whom are physicians.[44]

Honors/affiliations/awards

Selected works

Biomedical Research

Flier has published over 350 research papers papers and subject reviews, which have been jointly cited over 110.000 times, his overall h-index is 150.[48]

Most cited original research

His most cited original research papers are:

Most cited subject reviews

Most recent biomedical papers

Recent policy papers

Notes

See also: Harvard Medical School.

External links

Notes and References

  1. Web site: Jeffrey S Flier . 2022-06-12 . hms.harvard.edu . en.
  2. Web site: Jeffrey S. Flier . 2022-08-15 . neuro.hms.harvard.edu . May 2020 . en.
  3. Web site: Dorothy Flier Obituary - Brookline, MA. Dignity Memorial.
  4. An opponent to healthcare for all.Web site: Jeffrey S. Flier, MD, Dean of Harvard Medical School . dead . https://web.archive.org/web/20100413185923/http://hms.harvard.edu/public/news/bio.html . 2010-04-13 .
  5. Web site: Jeffrey S. Flier named next dean of Faculty of Medicine . Harvard Gazette . 11 July 2007 .
  6. Web site: Jeffrey S. Flier, MD . scholarrock.com.
  7. Web site: Strategic Planning at Harvard Medical School . October 2008 . 2010-10-13 . https://web.archive.org/web/20120310001534/http://hms.harvard.edu/public/strategy/P1_full.pdf . 2012-03-10 . dead .
  8. Web site: The Dean's Report 2008-2009 . 2008 . 2010-10-13 . https://web.archive.org/web/20120310001645/http://hms.harvard.edu/deans_report/pdfs/HMS_DR_0809.pdf . 2012-03-10 . dead .
  9. Web site: Flier . Jeffrey . New Dean for Faculty of Medicine . Harvard Medical School . 9 August 2016.
  10. Web site: About . 2022-08-15 . catalyst.harvard.edu . en-US.
  11. Web site: 2014-11-14 . "The World Is Waiting" . 2022-08-15 . Harvard Magazine . en.
  12. Web site: Medical School Overhauls Curriculum With Major Redesign News The Harvard Crimson . 2022-08-15 . www.thecrimson.com.
  13. Web site: HMS To Launch Biomedical Informatics Department News The Harvard Crimson . 2022-08-15 . www.thecrimson.com.
  14. Web site: Office for External Education . 2022-08-15 . hms.harvard.edu . en.
  15. 10.1126/science.170678 . Flier . JS . Kahn . CR . Roth . J . Bar . RS . Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance . Science . 190 . 4209 . 63–5 . 1975 . 170678. 1975Sci...190...63F . 42644407 .
  16. Book: Kahn . CR . Kasuga . M . King . GL . Grunfeld . C . Ciba Foundation Symposium 90 - Receptors, Antibodies and Disease . Autoantibodies to Insulin Receptors in Man: Immunological Determinants and Mechanism of Action . Ciba Foundation Symposium . Novartis Foundation Symposia . 90 . 90 . 91–113 . 1982 . 10.1002/9780470720721.ch7 . 6183063. 9780470720721 .
  17. 10.1073/pnas.75.9.4209 . Kahn . CR . Baird . KL . Jarrett . DB . Flier . JS . Direct demonstration that receptor crosslinking or aggregation is important in insulin action . Proceedings of the National Academy of Sciences of the United States of America . 75 . 9 . 4209–13 . 1978 . 279910 . 336081. 1978PNAS...75.4209K . free .
  18. Moller . DE . Flier . JS . Detection of an alteration in the insulin-receptor gene in a patient with insulin resistance, acanthosis nigricans, and the polycystic ovary syndrome (type a insulin resistance) . The New England Journal of Medicine . 319 . 23 . 1526–9 . 1988 . 2460770 . 10.1056/NEJM198812083192306.
  19. Moller . DE . Yokota . A . White . MF . Pazianos . AG . Flier . JS . A naturally occurring mutation of insulin receptor alanine 1134 impairs tyrosine kinase function and is associated with dominantly inherited insulin resistance . The Journal of Biological Chemistry . 265 . 25 . 14979–85 . 1990 . 10.1016/S0021-9258(18)77212-8 . 2168397. free .
  20. Web site: Flier JS . Maratos-Flier E . Biology of Obesity . Harrison's Principles of Internal Medicine . 1990 . 2010-10-13 . https://web.archive.org/web/20100819071502/http://www.mhprofessional.com/Medical/harrisons/table_of_contents.html#p5 . 2010-08-19 . dead .
  21. 10.1016/S0092-8674(03)01081-X . Flier . JS . Obesity wars: molecular progress confronts an expanding epidemic . Cell . 116 . 2 . 337–50 . 2004 . 14744442. free .
  22. Flier JS . Maratos-Flier E . What fuels fat . Scientific American . September 2007 . 297 . 3 . 72–81 . 10.1038/scientificamerican0907-72 . 17784627 . 2007SciAm.297c..72F .
  23. Lowell . BB . S-Susulic . V . Hamann . A . Lawitts . JA . Himms-Hagen . J . Boyer . BB . Kozak . LP . Flier . JS . 1993 . Development of obesity in transgenic mice after genetic ablation of brown adipose tissue . Nature . 366 . 6457 . 740–2 . 1993Natur.366..740L . 10.1038/366740a0 . 8264795 . 4244632.
  24. Ahima . RS . Prabakaran . D . Mantzoros . C . Qu . D . Lowell . B . Maratos-Flier . E . Flier . JS . 1996 . Role of leptin in the neuroendocrine response to fasting . Nature . 382 . 6588 . 250–2 . 1996Natur.382..250A . 10.1038/382250a0 . 8717038 . Rexford S. Ahima . 4331304.
  25. Howard . JK . Cave . BJ . Oksanen . LJ . Tzameli . I . Bjørbaek . C . Flier . JS . 2004 . Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3 . Nature Medicine . 10 . 7 . 734–8 . 10.1038/nm1072 . 15220914 . 8086930.
  26. Shimada . M . Tritos . NA . Lowell . BB . Flier . JS . Maratos-Flier . E . Mice lacking melanin-concentrating hormone are hypophagic and lean . Nature . 396 . 6712 . 670–4 . 1998 . 9872314 . 10.1038/25341. 1998Natur.396..670S . 4370377 .
  27. Badman . MK . Pissios . P . Kennedy . AR . Koukos . G . Flier . JS . Maratos-Flier . E . Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states . Cell Metabolism . 5 . 6 . 426–37 . 2007 . 17550778 . 10.1016/j.cmet.2007.05.002. free .
  28. Flier . JS . Cook . KS . Usher . P . Spiegelman . BM . 1987 . Severely impaired adipsin expression in genetic and acquired obesity . Science . 237 . 4813 . 405–8 . 1987Sci...237..405F . 10.1126/science.3299706 . 3299706.
  29. Kokoeva . MV . Yin . H . Flier . JS . 2005 . Neurogenesis in the hypothalamus of adult mice: potential role in energy balance . Science . 310 . 5748 . 679–83 . 2005Sci...310..679K . 10.1126/science.1115360 . 16254185 . 35162566.
  30. Shi . Hang . Kokoeva . Maia V. . Inouye . Karen . Tzameli . Iphigenia . Yin . Huali . Flier . Jeffrey S. . 2006 . TLR4 links innate immunity and fatty acid-induced insulin resistance . The Journal of Clinical Investigation . 116 . 11 . 3015–3025 . 10.1172/JCI28898 . 0021-9738 . 1616196 . 17053832.
  31. Flier . J. S. . Young . J. B. . Landsberg . L. . 1980-10-23 . Familial insulin resistance with acanthosis nigricans, acral hypertrophy, and muscle cramps . The New England Journal of Medicine . 303 . 17 . 970–973 . 10.1056/NEJM198010233031704 . 0028-4793 . 6997748.
  32. Flier . Jeffrey S. . 2009 . Health care reform: without a correct diagnosis, there is no cure . The Journal of Clinical Investigation . 119 . 10 . 2850–2852 . 10.1172/jci41033 . 1558-8238 . 2752105 . 20069708.
  33. News: Flier . Jeffrey . 17 November 2009 . Health 'Reform' Gets a Failing Grade . Wall Street Journal . 16 August 2012.
  34. Flier . Jeffrey S. . Rhoads . Jared M. . 2020 . The US Health Provider Workforce: Determinants and Potential Paths to Enhancement . Perspectives in Biology and Medicine . 63 . 4 . 644–668 . 10.1353/pbm.2020.0053 . 1529-8795 . 33416803. 229355605 .
  35. Flier . Jeffrey S. . 2019 . Credit and Priority in Scientific Discovery: A Scientist's Perspective . Perspectives in Biology and Medicine . 62 . 2 . 189–215 . 10.1353/pbm.2019.0010 . 1529-8795 . 31281118. 132797746 . free .
  36. Glass . David J. . Flier . Jeffrey S. . 2017-11-07 . Dealing with Consequences of Irreproducibility and Modifying the Published Literature: Retractions versus Revisions . Cell Metabolism . 26 . 5 . 695–696 . 10.1016/j.cmet.2017.10.010 . 1932-7420 . 29117541. free .
  37. Flier . Jeffrey S. . 2021 . Misconduct in Bioscience Research: a 40-year perspective . Perspectives in Biology and Medicine . 64 . 4 . 437–456 . 10.1353/pbm.2021.0035 . 1529-8795 . 34840150. 244724698 .
  38. Flier . Jeffrey S. . Loscalzo . Joseph . 2017 . Categorizing biomedical research: the basics of translation . FASEB Journal . 31 . 8 . 3210–3215 . 10.1096/fj.201700303R . free . 1530-6860 . 5503706 . 28765169.
  39. Flier . Jeffrey S. . 2017-05-02 . Conflict of Interest Among Medical School Faculty: Achieving a Coherent and Objective Approach . JAMA . 317 . 17 . 1731–1732 . 10.1001/jama.2017.1751 . 1538-3598 . 28464148.
  40. News: Flier . Jeffrey . January 3, 2019 . Against diversity statements . The Chronicle of Higher Education . February 6, 2023.
  41. News: Flier . Jeffrey . June 19, 2019 . Removing portraits — a mistaken approach to promoting diversity in medicine . Boston Globe . February 6, 2023.
  42. News: Wadman . Meredith . February 3, 2023 . David Sabatini, biologist fired for sexual misconduct, lands millions from private donors to start new lab . Science . February 6, 2023.
  43. Web site: Flier and Maratos-Flier Research Lab at Beth Israel Deaconess Medical Center .
  44. Web site: Sarah Flier, MD, Joins BIDMC . 1 September 2010 . 2010-09-29 .
  45. Web site: Jeffrey S. Flier, MD, Receives American Diabetes Association's Distinguished Research Award . 9 June 2008 . 2010-10-18 . https://web.archive.org/web/20120309055815/http://professional.diabetes.org/UserFiles/File/Scientific%20Sessions/2008/Media%20Page/Renold%20Flier.pdf . 9 March 2012 . dead .
  46. Web site: Graduation Ceremony, McEwan Hall: Honorary Graduate: Jeffrey S. Flier . 2010 . 2010-10-18 . 2020-01-10 . https://web.archive.org/web/20200110015136/http://www.docs.sasg.ed.ac.uk/registry/grads/grad_photos/030710AM/index.htm . dead .
  47. Web site: NIDDK Welcomes Five New Members to Advisory Council . 11 March 2005 . 2010-10-18 . https://web.archive.org/web/20101220191926/http://www.nih.gov/news/pr/mar2005/niddk-11.htm . 20 December 2010 . dead .
  48. Web site: Jeffrey S. Flier . 2022-06-18 . scholar.google.com.